Bottom line: even if the FDA eventually recommends that certain peptides can be compounded under Section 503A, many stakeholders could still be blocked by the requirement to source pharmaceutical-grade API from an FDA-registered establishment with a Certificate of Analysis and by FDAs demonstrated willingness to police marketing claims around compounded drugs
This can include bowel dysmotility, gastroparesis, or Parkinsons disease
Wednesday, I take the NAD+, Friday, I take NAD+ and Lipo-C
Individual responses vary based on gut health, dosage, and hydration status
doi: 10.1097/CCO.0b013e32834d816a 92 ZhaoLHuangYZhengJ
During the first few days, many patients experience mild gastrointestinal symptoms such as nausea or mild discomfort as their digestive system becomes accustomed to the medications action